MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Differences in EEG spectral features in Alzheimer’s and Parkinson’s disease with mild cognitive impairment

    M. Ajcevic, M. Catalan, P. Polverino, K. Iscra, G. Mazzon, C. Bertolotti, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to examine changes in brain cortical activity using high-density EEG in subjects with mild cognitive impairment (MCI) due…
  • 2023 International Congress

    Reduced non-REM sleep in Parkinson disease is associated with memory impairment and non-motor symptom burden

    S. Shah, C. Dintino, S. Lageman, N. Mukhopadhyay, E. Shelton, S. Holden, J. Broussard, L. Cloud, M. Barrett, B. Berman (Richmond, USA)

    Objective: To evaluate the relationship between sleep architecture and cognitive function in Parkinson disease (PD). Background: About half of PD patients develop mild cognitive impairment…
  • 2023 International Congress

    Risk factors of sleep disordered breathing in Veterans with Parkinson’s disease.

    A. Sarwar (PEARLAND, USA)

    Objective: To investigate factors associated with the risk of sleep disordered breathing (SDB) in Veterans with Parkinson's disease (PD). Background: Sleep disordered breathing is common…
  • 2023 International Congress

    The diagnosis value of dopaminergic responsiveness of Parkinson’s disease: a systematic review and meta-analysis

    WY. Kou, HH. Cai, FT. Feng (beijiing, China)

    Objective: aimed to confirm the diagnostic value/accuracy of levodopa and/or apomorphine challenge test in parkinsonian syndromes (PDS) to assess their value in the diagnosis of…
  • 2023 International Congress

    Integrative brain states facilitate the expression of Parkinson’s tremor

    MF. Dirkx, M. Shine, RC. Helmich (Nijmegen, Netherlands)

    Objective: To test the hypothesis that fluctuations in integrative brain states and/or arousal drive spontaneous fluctuations in PD rest tremor. Background: Parkinson’s disease (PD) rest…
  • 2023 International Congress

    Baseline fluid biomarkers in a phase 2 clinical trial in Parkinson’s Disease

    T. Kustermann, G. Pagano, H. Svoboda, T. Nikolcheva, K. Taylor (Basel, Switzerland)

    Objective: To evaluate baseline CSF and blood-based biomarkers of pathology in early-stage Parkinson’s Disease (PD) participants in the phase 2 clinical trial PASADENA. Background: Observational…
  • 2023 International Congress

    PDQ-39 predicts quality of life improvement following neurostimulation for Parkinson’s disease: Prospective observational study

    L. Torrão, M. Rosas, J. Massano, A. Oliveira, C. Chamadoira, M. Rito, J. Guimarães, C. Soares (Póvoa de Varzim, Portugal)

    Objective: The primary outcome was assessing QoL of a cohort of patients with PD before and after undergoing DBS surgery, measured using PDQ-39 questionary. Secondary…
  • 2023 International Congress

    Detecting clinical fluctuations in chronic biomarker recordings: experiences with chronic subthalamic peak beta band recordings in a large Parkinson’s disease patient cohort

    LK. Feldmann, J. Habets, V. D'Onofrio, V. Mathiopoulou, J. Busch, K. Faust, GH. Schneider, D. Gruber, G. Ebersbacher, AA. Kühn (Berlin, Germany)

    Objective: Since the understanding of electrophysiological biomarker dynamics during every-day activities is crucial for adaptive deep brain stimulation (aDBS), this study aims to investigate characteristics…
  • 2023 International Congress

    Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients

    T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel (Essen, Germany)

    Objective: The present study cross-sectionally and longitudinally explores the predictive value of subjective cognitive decline (SCD) regarding objective cognitive decline in a large clinical sample…
  • 2023 International Congress

    Action- and emotion-related language abilities in Slovenian-speaking individuals with Parkinson’s disease – a background normative study

    ž. Drakulić Gorše, C. Manouilidou, M. Trošt (Ljubljana, Slovenia)

    Objective: To prepare action-related (AR) and emotion-related (ER) linguistic stimuli in Slovenian language to test language functions in Parkinson's disease (PD) patients. Background: PD patients…
  • « Previous Page
  • 1
  • …
  • 250
  • 251
  • 252
  • 253
  • 254
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley